SOURCE: Horizon Pharma

Horizon Pharma

October 02, 2013 07:30 ET

Horizon Pharma to Present at the 12th Annual BIO Investor Forum

DEERFIELD, IL--(Marketwired - Oct 2, 2013) - Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Todd Smith, executive vice president and chief commercial officer, will present at the 12th Annual BIO Investor Forum on Wednesday, October 9, 2013 at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) in San Francisco, CA. Mr. Smith will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at
http://ir.horizon-pharma.com

About Horizon Pharma
Horizon Pharma, Inc. is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS/LODOTRA, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire, in-license and/or co-promote additional innovative medicines where it can execute a targeted commercial approach in specific therapeutic areas while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit www.horizonpharma.com.

Contact Information

  • Contacts
    Robert J. De Vaere
    Executive Vice President and Chief Financial Officer
    Email Contact

    Investors
    Kathy Galante
    Burns McClellan, Inc.
    212-213-0006
    Email Contact